Loading market dashboard
Eli Lilly and Company
LLYHealthcareNYSEUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Eli Lilly and Company · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $130.46B | $123.23B - $139.47B | $41.88B | $63.693 | 11 |
| Dec 2029 | $120.01B | $113.36B - $128.30B | $38.53B | $57.765 | 11 |
| Dec 2028 | $110.09B | $109.90B - $110.29B | $35.34B | $51.335 | 23 |
| Dec 2027 | $98.19B | $92.63B - $101.28B | $31.52B | $44.555 | 21 |
| Dec 2026 | $84.79B | $82.80B - $87.92B | $27.22B | $36.578 | 18 |
| Dec 2025 | $63.86B | $62.16B - $64.93B | $20.50B | $23.59 | 18 |
| Dec 2024 | $45.10B | $45.02B - $45.40B | $14.48B | $12.833 | 14 |
| Dec 2023 | $38.92B | $36.76B - $41.61B | $12.50B | $8.154 | 13 |
| Dec 2022 | $28.59B | $26.81B - $30.14B | $8.03B | $7.636 | 6 |
| Dec 2021 | $28.04B | $26.30B - $29.56B | $8.30B | $8.132 | 7 |
| Dec 2020 | $24.38B | $22.86B - $25.70B | $7.79B | $7.37 | 11 |
| Dec 2019 | $22.14B | $20.77B - $23.35B | $10.06B | $5.814 | 6 |